Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi
, Federico Pietrocola
, José Manuel Bravo-San Pedro
, Ravi K. Amaravadi
, Eric H. Baehrecke
, Francesco Cecconi
, Patrice Codogno
, Jayanta Debnath
, David A. Gewirtz
, Vassiliki Karantza
, Alec Kimmelman
, Sharad Kumar
, Beth Levine
, Maria Chiara Maiuri
, Seamus J. Martin
, Josef Penninger
, Mauro Piacentini
, David C. Rubinsztein
, Hans Uwe Simon
, Anne Simonsen
Andrew M. Thorburn, Guillermo Velasco, Kevin M. Ryan, Guido Kroemer
Show 4 others
Show less
Centre de Recherche des Cordeliers
Université Paris-Sud
Université Paris Cité
University of Pennsylvania
University of Massachusetts Medical School
Danish Cancer Society
University of Rome Tor Vergata
Institut Necker-Enfants Malades (INEM)
CNRS
University of California at San Francisco
Virginia Commonwealth University
Merck & Co.
Dana-Farber Cancer Institute
University of South Australia
University of Texas Southwestern Medical Center
Trinity College Dublin
Institute of Molecular Biotechnology
IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani - Roma
University of Cambridge
University of Bern
University of Oslo
University of Colorado Anschutz Medical Campus
Complutense University
Hospital Clínico San Carlos de Madrid
Beatson Institute for Cancer Research
Assistance publique – Hôpitaux de Paris
Research output
:
Contribution to journal
›
Article
›
peer-review
1074
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Autophagy in malignant transformation and cancer progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Malignant Transformation
100%
Carcinogenesis
20%
Anticancer
10%
Environmental Stress
10%
Homeostasis
10%
Tumor Progression
10%
Immunosurveillance
10%
Chemistry
Cope Reaction
100%